USP37 promotes deubiquitination of HIF2α in kidney cancer

Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss

(2020) Xijuan Liu et al.   MOLECULAR CELL

Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap

(2019) Jüri Reimand et al.   Nature Protocols

TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss

(2019) Lianxin Hu et al.   Cancer Discovery

VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma

(2018) Jing Zhang et al.   SCIENCE

Salmon provides fast and bias-aware quantification of transcript expression

(2017) Rob Patro et al.   NATURE METHODS

USP37 deubiquitinates Cdt1 and contributes to regulate DNA replication

(2016) Santiago Hernández-Pérez et al.   Molecular Oncology

Targeting renal cell carcinoma with a HIF-2 antagonist

(2016) Wenfang Chen et al.   NATURE

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models

(2016) Hyejin Cho et al.   NATURE

The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression

(2015) Christina Yeh et al.   CURRENT BIOLOGY

EglN2 associates with the NRF1‐PGC1α complex and controls mitochondrial function in breast cancer

(2015) Jing Zhang et al.   EMBO JOURNAL

Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis

(2014) X-D Liu et al.   ONCOGENE

USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer

(2014) J Pan et al.   ONCOGENE

SQSTM1 Is a Pathogenic Target of 5q Copy Number Gains in Kidney Cancer

(2013) Lianjie Li et al.   CANCER CELL

HIF1α deubiquitination by USP8 is essential for ciliogenesis in normoxia

(2013) Albino Troilo et al.   EMBO REPORTS

STAR: ultrafast universal RNA-seq aligner

(2012) Alexander Dobin et al.   BIOINFORMATICS

Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression

(2012) Johannes Schödel et al.   NATURE GENETICS

The VHL/HIF axis in clear cell renal carcinoma

(2012) Chuan Shen et al.   SEMINARS IN CANCER BIOLOGY

Deubiquitinase USP37 Is Activated by CDK2 to Antagonize APCCDH1 and Promote S Phase Entry

(2011) XiaoDong Huang et al.   MOLECULAR CELL

Int6 /eIF3e Silencing Promotes Functional Blood Vessel Outgrowth and Enhances Wound Healing by Upregulating Hypoxia-Induced Factor 2α Expression

(2010) Li Chen et al.   CIRCULATION

Control of Cyclin D1 and Breast Tumorigenesis by the EglN2 Prolyl Hydroxylase

(2009) Qing Zhang et al.   CANCER CELL

Defining the Human Deubiquitinating Enzyme Interaction Landscape

(2009) Mathew E. Sowa et al.   CELL

Model-based Analysis of ChIP-Seq (MACS)

(2008) Yong Zhang et al.   GENOME BIOLOGY